Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genprex Inc

GNPX
Current price
0.23 USD -0.019 USD (-7.60%)
Last closed 0.24 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 086 048 USD
Yield for 12 month -81.74 %
Week
Month
Year
GNPX
21.11.2021 - 28.11.2021

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746

Analytics

WallStreet Target Price

8 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-23 830 719 USD

Last Year

Current Quarter

Last Quarter

Key Figures GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -31 650 372 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -84.97 %
PEG Ratio
Return On Equity TTM -158.09 %
Wall Street Target Price 8 USD
Revenue TTM
Book Value 0.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.61 USD
Diluted Eps TTM -0.61 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GNPX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.0797
Price Book MRQ 1.1568

Financials GNPX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GNPX

For 52 weeks

0.19 USD 1.94 USD
50 Day MA 0.29 USD
Shares Short Prior Month 1 638 418
200 Day MA 0.69 USD
Short Ratio 3.1
Shares Short 1 342 234
Short Percent 2.29 %